Proceedings of the international session of the 26th annual meeting October 18–20, 1984—Chiba,...
Transcript of Proceedings of the international session of the 26th annual meeting October 18–20, 1984—Chiba,...
GastroenterologiaJaponica Vol. 20, No. 3 Copyright �9 1985 by The Japanese Society of Gastroenterology Printed in Japan
P R O C E E D I N G S O F T H E I N T E R N A T I O N A L S E S S I O N O F
T H E 2 6 T H A N N U A L M E E T I N G
October 18-20, 1 9 8 4 - - C h i b a , Japan
C h a i r m a n : Kun io O K U D A , M . D . , Ph .D .
Modera to r s :
International symposium (1):
Hepatitis vaccine R . P . B E A S L E Y ( T a i w a n ) a n d Tosh io S H I K A T A (Japan)
Cl in ica l t r ial of HB vaccine in the families
of HBV carriers
Y. KATO, H. MIYAMORI, M. UNOURA,
N. OHMIZO, N. TANAKA, K. KOBAYASHI
and N. H A T T O R I
1st Dept Intern Med, Sch Med,
Kanazawa Univ
An HB vaccine was given to 75 subjects and anti-
body formation in response to vaccination was
studied. They consisted of hospital workers and
families of HBeAg positive carriers. The subjects
younger than 10 years were given 10 pg of vaccine
and those who were 10 years or older 20 pg. The
second and third injections were given 4 and 24
weeks after the first. Twenty-eight weeks after the
first vaccination, anti-HBs was detected in 70 out of
the 75 subjects (93%). The anti-HBs response was
more marked in females and in younger individuals,
but the differences between males and females and
between the younger and older groups were not sig-
nificant. In subjects under 10 years of age, an ade-
quate anti-HBs response was obtained with 10 pg of
HBsAg protein. No clear correlation could be eluci-
dated between anti-HBs response and HLA because
even the siblings who showed a same low anti-HBs
response did not have one HLA haplotype in com-
mon, and a difference was observed in anti-HBs re-
sponse even among siblings who had the same two HLA haplotype.
A cl inical t r ial of hepati t is B vaccine in hospital employees
Y. ARAKAWA, S. AMAKI and T. SHIKATA
Depts Med and Pathol, Nihon Univ
Sch Med, Tokyo, Japan
We have carried out a clinical trial of hepatitis B
vaccine prepared in Japan. The study subjects con-
sisted of HBsAg-negative 205 hospital employees.
All recipients received subcutaneously three injec-
tions of HB vaccine at 0, 4 and 24 (or 20) weeks, at
three different dose levels of 16/./g, 40 pg and 20/./g
in Phase I, II and III studies, respectively. Ten per-
sons, who were positive for HBsAb before vaccina-
tion, showed an anamnestic response. Of the re-
maining HBsAb-negative 195 recipients, 179 de-
veloped a primary HBsAb response (82/95 in males
and 97/100 in females) and the other 16 failed to re-
spond to the vaccine. The higher immune response
rate was confirmed in recipients aged less than 50,
but a sexual difference in immune response was not
significant. None of the vaccinated persons showed
any sign of hepatic injury. The incidence of local or
general side effects was low. Peripheral T cell subsets
showed no significant difference between good and
weak responders to the vaccine. The overall rate of
HBsAb-positive vaccine recipients remained almost
unchanged during the 15-month follow-up period.
However, several vaccinees who lost the antibody 30
months later, were among the weak responders. The
HB vaccine was suggested to be safe an efficacious
when tested in a high risk population.
Hepatitis B vaccine trials in Korea
Bang-Hyun LIU
274 Proceedings of26th Annual Meeting Vol. 20, No. 3
Dept Med, Pusan Natl Univ Hosp, Pusan, Korea
Chronic HBV carr ier is es t imated more than three
& hal f mill ion in Korea and a round 8 - 1 0 % of these
carriers will be chronic hepatopathies . Since the
licensure of an inact ivated hepati t is B vaccine, H-B
Vax is r ecommended for immuniza t ion of infants,
chi ldren & adults who are exposed to h igh risk of he-
patit is B imfection.
H-B Vax (Merck) was in t roduced in Korea in July
1982 as a commercia l base. Subseqhently Pasteur
Vaccine in Aug. 1982, and currently Hepavax B,
Green Cross Co., Korea in Oct. 1983 are also avail-
able here and this t ime HBV vaccinat ion is widely
administered.
The authors studied on immune response of
heal thy adults to HB vaccine at the six months after
3 times injection and they also observed the i m m u n e
response in neonates to HB vaccine & HBIG.
Fur ther follow up studies on ant ibody response
after HB vaccinat ion will be carr ied out in future in
addi t ion to this pre l iminary report . And fur ther
prevention of hepati t is B infection will be expected
by active vaccinat ion p rog ram at highly contami-
na ted areas.
Efficacy of HBIG and HB vaccine i n
preventing perinatal transmission of HB virus to children born
to HBe antigen-positive carrier mothers
K. KANAI, S. M O R I O K A , M. NISHIDA,
H. N O T O , K. T A K A H A S H I and
K. M A T S U S H I T A
Depts Med, Pediatr, Obst and Gynecol and Epidemiol, Hamamatsu
Univ Sch Med, Shizuoka
The efficacy of the combina t ion of ant ihepat i t i s B
immunoglobu l in (HBIG) and HB vaccine for the
prevent ion of verical t ransmission of HB virus to the
babies born to eAg-positive HB carrier mothers has
been investigated. Babies received 150 m g of
H B I G . F (ab')~ i.v. within 2 hours of delivery and
serum anti-HBs ant ibody (HBsAb) titers were main-
ta ined by s.c. inject ion of 1 ml each of HBIG at 1
day, 2 and 5 mo after bir th , Three dose of HB vac-
cine conta in ing 32/~g HBsAg proteins was s tar ted at
3 mo (6 mo in some cases) after delivery at 1 mo
intervals. It has been disclosed that 58 of 59 babies
who are enrolled in this trial and older than 12 mo
of age, were actively immunized against HBsAg.
Vaccine which contains a lum adjuvant was found to
be more effective in produc ing HBsAb than the vac-
cine without adjuvant . Serum HBsAb titers were
well ma in ta ined in most babies who were actively
immunized without the addi t ional adminis t ra t ion of
vaccine. Mean serum HBsAb titers (PHA) 3, 6, 12
and 18 mo after ob ta in ing active immuniza t ion was
4.4, 4.3, 3.9 and 4.2, respectively. None of t h e
babies t reated by HBIG and HB vaccine revealed
positive HBcAb in their sera at the age of 12 mo. No
side effect was observed.
Immunoprophylaxis on HBV perinatal infection
R. Palmer BEASLEY and Lu-Yu H W A N G
15% to 20% of popula t ion in Ta iwan are HBV
carriers. The infections most occur in infants and
chi ldren often from their own monthers . W h e n the
mothe r is e ant igen positive (40 % of carriers) at least
90% of infants become carriers from the per ina ta l
infection. Passive prophylaxis with Hepati t is B Im-
mune Globul in (HBIG) only can prevent 75% of them from carriers. However, HB vaccine has shown
immunogenic in adults and children. For determin-
ing the immunogenic i ty and efficacy of HB vaccine (Merck Sharp & Dohme) against per inata l transmis-
sion in newborns, the clinical trial was conducted
since 1981. It demons t ra ted 100% i m m u n e response to 3 doses vaccine (20/~g) in 38 newborns. Efficacy
was a randomized trial for prevention of infants
born to e ant igen positive carr ier mothers . Since
1981 more t han 50,000 p regnan t women were
screened for HBsAg in Taipei . There are 260 infants
randomized to receive HBIG plus vaccine or HB
vaccine alone. Among the infants receiving HBIG
plus vaccine only 6% developed HBsAg carriers,
compared with 88% a m o n g the controls. A m o n g those infants who received HB vaccine but no
HBIG, 23% became HBsAg carriers. All the re-
ma in ing infants who d idn ' t become carriers develop antibodies.
June 1985 Proceedings of 26th Annual Meeting 275
The efficacy of HBIG in combination with vaccine
(94%) was superior to HBIG alone (71%) or vaccine
alone (75%). HBIG should be given immediately
after birth. To maximize compliance and minimize
costs, we recommend that HBV vaccination be ini-
tiated in the first week of life. For further evaluation
of the imrnunogenicity and efficacy of lower dose
vaccine, we have recruited 500 infants. The prelimi-
nary result will be known soon.
Efficacy of HB vaccine on HBV maternal i n fan t transmission
M. YANO, M. SHIMA, E. TSUNODA,
M. KOGA and T. M I N A M I N O
Inst Clin Res, Nagasaki Chuo Natl Hosp, Nagasaki, Japan
Prevention for HBV maternal infant transmission
is a very important treatment, especially in Asia
countries. 944 babies born to e antigen positive
mothers have been treated with passive or passive-
active immunization by our group study. All babies
were administrated HBIG just after birth and 1 or 2
additional HBIGs in every 3 months. We have ob-
served the efficacy of HB vaccine in 3 different sche-
dules. 171 babies are treated with schedule A, this is
a schedule of treatment with HBIG only. 108 babies
are treated with schedule B. In this schedule, HBIGs
are given 3 times, just after birth, 3 months and 6
months of age. HB vaccine is started at 6 months of
age and administrated 3 times. 665 babies are
treated with schedule C. In this schedule, HBIG is
given just after birth and 3 months of age. HB vac-
cine is given at 3 months, 4 months and 6 months of
age. The carrier rates of group A, B and C are
12.3%, 7.4% and 5.0%. 37 out of 944 babies
(3.9%) developed carrier state until 6 months of
age. There is no difference in the HBV carrier rates
of each group in this period. In the babies between 6
to 12 months of age, the HBV carrier rates of group
A, B and C are 3.4%, 4.9% and 1.2%. In the
babies of over 12 months of age, the carrier rates of
group A, B and C are 4 .5%, 0% and 0.7%. Preven-
tive efficacy with passive-active immunization is
better than with passive immunizat ion only. The de-
velopment of HBV carrier was restricted in the
babies who received HB vaccine around 3 month of
age compered with the babies who received after 6
months of age.
In ternat iona l s y m p o s i u m (2):
H e p a t i t i s v i r u s a n d h e p a t o c e l l u l a r carc inoma
Modera to r s : J . S U M M E R S (USA) a n d Masao O M A T A (Japan)
Clinico-epidemiological study of HBV carrier state
T. TSUJI, K. KAGAWA, T. OKUNO
and T. T A K I N O
3rd Dept Med, Kyoto Pref Univ Med, Kyoto, Japan
The aims were to investigate the prognosis, trans-
mission and annual incidence of carrier state. We
have done this study at HBV infectious district with
the most highest incidence (19%) in Japan for 10
years since 1974, where was a fishing village at the
coast of the Sea of Japan in Kyoto prefecture. There
were living about 300 people, who were detected an-
nual mass examination, and especially objected
same 103 people of them continuously. S-ALT and
others as liver function test examined, and HBsAg in
serum by R-PHA & RIA, anti-HBs by PHA & RIA,
HBeAg & anti-HBe by RIA, and anti-HBc by IAHA
& RIA. AFP & CEA used RIA. Uhrasonographic
method was done as the screening of HCC for 2 years
recently.
Results: 1) Carrier state was decreased annually
from 3rd year of the most highest levels (25.2%).
Therefore the incidence in 1983 was 18.3%. This
tendency was noticed female. 2) Some of carrier
states disappeared naturally, who was 17.1% and
this tendency also was female. Natural seroconver-
sion of HBsAg revealed that the incidence was
50.0%. They had all anti-HBe and the mean age
276 Proceedings of26th AnnualMeeting Vol. 20, No. 3
was 50.5 years old. The time interval took in 3 to 4
years. 3) HCC confirmed 2 cases of carrier states, in
whom were male and female each, and the inci-
dence of all candidates (232) was 0.86%, in which
was 0.9% of males and 0.8% of females. The inci-
dence of all carrier states (45) was 4.4%, in which
was 4.3% of males and 4 ,5% of females. These re-
sults were suggested that HBV could be had some
behavior of the onchogenesity in liver cell.
A prospective study on the development of hepatocellular carcinoma from
liver cirrhosis
Takeshi K U R I H A R A and Hiroshi OBATA
Inst Gastroenterol, Tokyo Women's Med Coll
We made a prospective study on the development
of hepatocellular carcinoma (HCC) in patients with
liver cirrhosis.
Among the patients who were diagnosed as liver
cirrhosis during the period from April 1970 until
May 1977, 110 patients, on whom we were able to
continue follow-up observations until May 1984,
were used as the subjects of the present study. Those
patients were classified into three groups by the anti-
HBc titer (IAHA Method) to carry out the investiga-
tion. Group I included those who were continuously
infected with HBV (anti-HBc titer~210), Group II,
those who has the infection in the past (anti-HBc
titer<29), and Group III, those who did not have
the infection.
HCC developed in 33 cases (30.0%) which were
further broken down as follows: 10 out of 33 cases of
Group I, 13 out of 35 cases of Group II, and 10 out
of 42 cases of Group III. The average observation
period until the development of HCC was 3 years
and 9 months in Group I, 5 years and 5 months in
Group II, and 5 years and 11 months in Group III,
In Group I, HCC developed at the comparatively
early stage and a decreasing tendency was observed
in those cases that were observed for a longer period
of time. On the other hand, in the non-infected
group, there were many cases in which development
of HCC occurred after a long period of observation,
indicating a difference between the two groups.
Hepatocellular carcinoma and HBV infection
R. Palmer BEASLEY
Hepatocellular carcinoma (HCC) is one of the commonest cancers in the world and chronic HBV virus infection is the usual underlying event preceed- ing its occurrence. Throughout the world most cases occur among persons with serological markers of
HBV infection, most of whom are HBsAg carriers; only a small proportion show no evidence of prior HBV infection. Even though there is striking world- wide geographic variation in the incidence of HCC,
there is a close international correlation with the prevalence of HBsAg carriers. Many HBV carriers
in the world were probably infected in early life by their own carrier mothers, and mother to child transmission appears to have unique importance in relation to HCC.
In a long term followup study begun in 1975 of 22,707 middleage men in Taiwan, during which there has been an average of 6.2 years of followup per man. 116 cases of HCC have occurred: 113 among 3,454 HBsAg carriers, and 3 among 19,253 non-carriers, a relative risk of 217. The incidence was 528/100,000/year among carriers, and the esti- mated life-time risk of death from HCC and /o r cir- rhosis is approximately 40 %.
The risk of HCC among HBV carriers in the Taiwan prospective study was related to the pres- ence of the following factors among the study sub- jects when they entered the study: 1) clinical cirrho-
sis, 2) history of hepatitis, 3) elevated serum anti- HBc IgM, 4) e antigen serum positivity. Even
though HBV is the major cause of HCC, it is prob- ably not the only one. Other factors, especially aflatoxins, probably cause HCC and there may also be causitive interaction.
T h e role of HBV in the development of hepatocellular carc inoma
K. OKITA, T. KONISHI and Y. KADO
Dept Med, Yamaguchi Univ, Ube, Yamaguchi
We have performed the following clinico-patho-
logical studies for elucidation of possible role of
June 1985 Proceedings of 26th Annual Meeting 277
HBV-in hepatocarcinogenesis. Since 1970, 206 cases
of HCC have been collected and 45.2% of them
were positive for HBV-infection in the past. How-
ever, regarding juvenile case of HCC ranging from
11 to 39 years old, 10 out of 12 cases (83.3%)
showed positive for HBsAg or HBsAb. Integration of
HBV-DNA into cancer cell DNA was assayed using
surgically resected materials and was observed in all
cases who showed HBV associated markers in the
sera. These evidences suggest the mode of integra-
tion of HBV-DNA in host cell DNA must be impor-
tant for elucidation of close relationship between
HBV-infection and cancer development. In addi-
tion, in 14 cases who were followed over 3 years
through preneoplastic state, the validities of para-
meters for high risk group of HCC and preneoplastic
lesions directly related to cancer-development which
we already reported were estimated again.
Integration of hepati t is B virus DNA in neoplastic and non-neoplastic
liver diseases
O. YOKOSUKA, M. OMATA, F. IMAZEKI,
M. RYUU and K. OKUDA
1st Dept Med and 2nd Dept Surg, Chiba
Univ Sch Med, Chiba, Japan
By Southern blot hybridization technique using
~2P-labeled HBV DNA, integration of HBV DNA in
liver tissue was studied in 63 cases of non-neoplastic
chronic liver diseases (33 CPH, 19 CAH, 11 cirrho-
sis). Various forms of replicative free viral DNAs
were found in 34 of 38 (89%) of HBeAg positive, in
4 of 18 (22%) of anti-HBe positive, and in 2 of 7
(29%) both negative cases. High molecular weight
radioactive signals on electrophoresis were found in
4 of 63 (6%) cases of non-neoplastic liver diseases.
Two such patients had discrete bands of HBV DNA
after EcoR I and Hind III digestions.
Similarly, integration of HBV DNA was studied
in 14 cases of hepatocellular carcinoma (HCC).
Integrated HBV DNA was detected in all 4 HBsAg
seropositive and 3 of 10 (30%) seronegative cases.
Among these 3 HBsAg seronegative HCC cases who
had integrated HBV DNA, one had been thought to
be a sequla to non-A non-B post-transfusion chronic
liver disease, and another alcoholic liver disease by
conventional examinations.
Conclusion: In non-neoplastic liver diseases, pres-
ence of HBeAg in serum indicates frequent and
large quantities of free viral DNA in liver tissue, but
the presence of anti-HBe, believed to indicate ab-
sence of infectivity, does not necessarily exclude it.
By the application of molecular biology techniques,
new fields have been developed in the study of the
role of HB virus in hepatocarcinogenesis.
State of hepatit is B virus DNA in liver and hepatocellular carcinoma
tissues of HBV carriers
Keiji M I T A M U R A
Inst Clin Med, Univ of Tukuba, Ibaraki, Japan
Molecular hybridization using cloned hepatitis B
virus DNA (HBVDNA) was applied to liver and
tumor tissues from HBV carriers and patients with
hepatocellular carcinoma for determination of state
of HBVDNA in liver and hepatocellular carcinoma.
Free HBVDNA was detected in lliver from thirty-
seven of fifty-two HBV carriers and integration of
HBVDNA into hepatocellular DNA was not iden-
tified in liver from HBV carriers.
Integrated HBVDNA was identified in hepato-
cellular carcinoma tissues from fourteen of fifteen
patients persistently infected with HBV. No inte-
grated HBVDNA was detected in liver tissue ad-
jacent to the tumor. No free HBVDNA was also
identified in liver tissue from a half of patients with
hepatocellular carcinoma.
These results suggest that integration of HBV-
DNA into hepatocellular DNA occurs in conjunc-
tion with malignant transformation.
Hepati t is B virus infection and hepato- cellular carcinoma in Taiwan
D.S. CHEN, J .L. SUNG, M.Y. LAI,
J.C. SHEU and H.C. HSU Dept Intern Med, Natl Taiwan Univ
Coll Med, Taipei, Taiwan, ROC
Persistent hepatitis B virus (HBV) infection and
278 Proceedings of26th AnnualMeeting Vol. 20, No. 3
hepatocellular ca rc inoma (HCC) are prevalent in
Taiwan. To study their relationship, the following
studies were performed.
In 247 HCC patients, the serum HBsAg preva-
lence was 88% in contrast to 15% in heal thy adults.
The HBsAg titer tended to be low and did not corre-
late with the frequent ly coexisting m a c r o n u d u l a r
cirrhosis. Ant i -HBc was positive in 98%, but IgM
anti-HBc was present in only 3% of patients. Anti-
HBs was present in 19%. HBeAg/an t i -HBe was
positive in 17% and 79% respectively, correspond-
ing to the infrequest DNA polymerase activities and
serum HBV DNA. In seropositive patients, tissue
HBsAg was present in the non- tumor por t ion in
75-90%, and in HCC tissues in 3 -15%. Tissue
HBcAg was generally absent in these patients, e i ther
in tumor or non- tumor par t .
HBV genome in the liver tissues were analysed
with a sensitive probe and was found in 8 pat ients
studied. It was present in both tumor and non-
tumor tissue. In tegra t ion of HBV genome was found
in all of the 9 tissue specimens conta in ing adequa te
HBV DNA for analysis, including 4 pairs of t umor
and non- tumor liver f rom the same pat ient .
We conclude tha t persistent HBV infection is
common in our HCC patients, and a l though viral
replication is ineffective, the infection is closely re-
lated to HCC in Taiwan.
Close association between activated transforming gene and integrated
H B virus genome in the D N A
from a human hepatoma cell
l i ne (HCC-M)
T. NAKAMURA, T. MORIZANE and
M. TSUCHIYA
Dept Intern Med, Sch Med, Kefo Unfv, Tokyo, Japan
We investigated whether the DNA from a h u m a n
hepa toma cell line, HCC-M, which contains HBV
DNA as in tegrated form had a potent ial of trans-
forming N I H / 3 T 3 into cells with ma l ignan t na ture .
It was demonst ra ted in transfection exper iments
tha t a dose of 50 gg HCC-M DNA was able to induce
about 5 loci of cells growing free from contact in-
hibit ion. It was possible to induce secondary trans-
formants with the DNA from those p r imary trans-
formants. It seemed that those pr imary and secon-
dary t ransformants had a ma l ignan t phenotype
since they grew in semi-solid medium. The integra-
tion of h u m a n DNA sequences, HBV DNA and N-
ras gene in those t ransformants were examined by
the method of Southern using Blur 8, pHBV 114
and N-ras gene as probe. In N I H / 3 T 3 cells N-ras
gene was demonst rab le at two different sites on
agarose gel electrophoresis of Hind III-digested
DNA but the o ther two were not detected. In addi-
tion to the two bands demonst ra ted in N I H / 3 T 3
cells a novel b a n d hybridising to the N-ras probe was
detected only in the t ransformants . One of the
bands hybridising to the HBV DNA was located at
the position of the molecular weight same to the
novel band . These results suggest tha t HB virus
genome and an act ivated N-ras gene of HCC-M are
cotransferred to N I H / 3 T 3 cells and ma l ignan t
phenotypes are provided as the result. T rans fo rming
activity seems to reside in N-ras gene and it seems
likely tha t HB virus genome and N-ras gene are
closely associated on the DNA of HCC-M.
Establishment of a c o n t i n u o u s l y growing cell l i ne (WH257) of woodchuck
hepatocellular carcinoma and its characteristics
K. KOBAYASHI and M. U N O U R A
1st Dept Intern Med, Sch Med, Kanazawa Univ, Ishikawa, Japan
We have established an in vivo nude mouse model
system of woodchuck hepatocel lu lar ca rc inoma
(HCC) (Hepatology 3(5): 633, 1983). This system is
now in the 10th passage, and it produces WHsAg,
confirmed by our made specific monoclonal anti-
body to WHsAg, and the synthesis of a lbumin is also
proven, using an t i - r abb i t ant ibody to woodchuck
a lbumin. So we have tr ied to establish an in vitro
model system of a continuously growing cell line of
woodchuck HCC, using the serially t ransp lan ted
tumor of the nude mouse system.
T u m o r cells derived from the HCC in the 4th
passage were isolated by means of a collagenase per-
June 1985 Proceedings of 26th Annual Meeting 279
fusion technique, and inoculated into plastic dishes.
It has been successfully subcultivated 46 times (8
months) and the doubling time was 26 hours. The
production of WHsAg has not been proven, al-
though the intergration of WHV-DNA in cellular
DNA of WH257 was demonstrated by the Southern
blot technique method, examined by WHV-DNA
probe which was kindly provided by Dr. Gerin in
NIH in the U.S.A.. WH257 produces albumin
proven in its cytoplasm by the indirect immunofluo-
rescent method. This continuously growing cell line
(WH257) provides a definitive model for the study of
oncogenesis of human HCC related to hepatitis B
virus.
Moderators:
Internat ional symposium (3): I m m u n o l o g y and bowel diseases
P.E. H E R M A N S (USA) and Yutaka YOSHIDA (Japan)
Immunological study of lymphocytes isolated from the guinea pig
large intestine
K. OKAWA, K. KOBAYASHI, A. KITANO,
S. KUWAJIMA, H. HASHIMURA,
T. MATSUMOTO, M. HIKI, S. YAMAMOTO*
and Y. KINOSHITA**
*3rd Dept Intern Med and **2ncl Dept
Physiol, Osaka City Univ, Osaka
The purpose of this study was to evaluate the im-
munological characteristics of the large intestinal
lymphocytes in the guinea pig.
Intestinal mucosal lymphocytes (IL) of the large
bowel were isolated by the use of stainless sieve com-
bined with differential centrifugation, and were also
examined lymphocyte responses to polyclonal mito-
gens compaired with mesenteric lymph node lym-
phocytes (MLNL). Guinea pigs were immunized
with ovalbumin (OVA) and Freund's complete adju-
vant, and antigen specific responses of isolated IL
were examined.
Both IL and MLNL responded well to PHA,
ConA and PWM. In contrast, IL did not respond to
LPS, while MLNL responded to LPS. IL isolated
from guinea pig immunized with OVA responded to
OVA.
These results suggested that a majority of isolated
IL was thought to be T-cell, and the presence of the
immunological memory cells was revealed in the
large intestinal mucosa in the guinea pig.
Immunocytochemical observation on solitary lymphoid nodules in human
intestine: Possibity for their participation in local
immune responses
H. NAGURA, Y. SHIODA, Y. TSUTSUMI,
H. HASEGAWA and K. WATANABE
Inst Dis Mechanism ~ Control, Nagoya Univ Sch Med, Nagoya, Dept Surg, Nippon Med
Sch, Tokyo, and Dept Pathol ~ Cell Biol Res Lab, Tokai Univ Sch Med,
Isehara, Japan
Solitary lymphoid nodules are present in the
lamina propria throughout the human intestinal
tract, and look like small Peyer's pathes. If they have
the same functional ability as Peyer's patches, their
role on local immunity must be considerable. In the
present work we have characterized the cells in these
nodules by the peroxidase-labeled antibody method
using monoclonal antibodies detecting T and B
lymphocytes and rabbit antisera to human immuno-
globulins and J chain.
Results: Underlying the covering epithelium were
the lymphoid follicles themselves. The same prin-
ciples for defining T and B areas in the lymphnodes
applied equally well to those nodules. The dome re-
gion contained many macrophages and IgA plasma
cells as well as T and B lymphocytes. T cells in the
areas under the dome as well as in the inter- or peri-
follicular area were mainly composed of Leu 3a-
positive, helper/inducer T cells with a few Leu 2a,
280 Proceedings of26th AnnualMeeting Vol. 20, No. 3
suppressor/cytotoxic T cells. A follicular area con-
tained predominantly small lymphocytes expressing
a B cell surface marker, occasionally with germinal
center, where large and medium lymphocytes of a B
cell lineage and macrophages were present. It is
noteworthy that helper / inducer T cells and Leu 7-
positive, possible NK cells were present also in the
germinal center. This finding seems to be in agree-
ment with the dependence of the germinal center
reaction on the presence of T ceils and NK cells.
A new defect of the transport of IgM into the intestinal lumen in
selective IgA deficiency
T. KANOH*, O. NISHIDA*, H. UCHINO*,
T. MIYAKE** and Y. HISHITANI***
*lst Div, Dept Intern Med, **Dept Geriat, Kyoto Univ, Kyoto, and ***lst Div, Dept Intern Med, Osaka Med Coll,
Takatsuki, Japan
In selective IgA deficiency a large number of IgM- cells appear in the GI mucosa instead of IgA-cells
and IgM was detected on the luminal surface as a secretory form binding SC. In a 49-year-old woman with Sjoegren's syndrome (SS) having selective IgA deficiency, no IgM was found on the surface, al-
though there were many J chain positive (J+) IgM- cells in the lamina propria. In vitro binding of SC to IgM on the colonic sections was investigated in this case and another case of selective IgA deficiency (S.Y.) as a control whose colonic mucosa showed the localization of IgM on the lumina surface. The former showed no binding of free SC to the cyto- plasm of IgM-cells. Then, in order to study the capability of IgM from this case in binding SC, the following was performed. Using the antiserum against inaccessible antigens od SC, we determined the remainder of free SC after the incubation of polymeric Ig (pig). The more the remainder, the
less the capability of p lg in binding SC. Two mono- clonal IgM (J+) and four monoclonal pIgA (J+) were prepared. The % of SC-linked IgM or pIgA was 49% to 56% or 34% to 100%, respectively. Cohn Fr II and human albumin could not bind free SC at all. Only 3% of IgM from the patient bound free SC, whereas 42% of IgM from the case S.Y.
These interesting findings shown herein indicate a new defect of p ig transport system in the GI mucosa, which seemed to depend upon molecular defect of the patient's lgM. This is also one of abnormalities in IgM system in SS.
Immune response in intestinal
tuberculosis
D.K. BHARGAVA, B.N. TANDON, SHRINIWAS,
B.M.L. KAPUR, T.C. C H A W L A and
Usha KIRAN
All India lnst Med Sci, New Delhi, India
The immune response is one of the most potent
host factor against infection and its study could be
pertinent for morphological expression of disease
and demonstration of antibodies may help in evolv-
ing a serological test.
30 patients having ileal, ileocecal and colonic
tuberculosis were included in the study. The diagno-
sis was confirmed by histology and /o r bacterial
isolation. The immune response was evaluated by
PPD test, DNCB (Dinitrochlorbenzene) skin sen-
sitization, leukocyte migration inhibition (LMI) and
soluble antigen fluorescent antibody test (SAFA).
The PPD response was significantly positive in
95.45% patients. DNCB was negative in 45% and
positive in 55% (majority 2+) of patients. LMI was
positive in 77%. There was good correlation be-
tween PPD response and LMI. These findings indi-
cate that there is a subtle defect in cell mediated im-
mune response in patients of intestinal tuberculosis.
The SAFA test was positive in 25 (83.3%) of 30 pa-
tients. The false positive result was observed only in
one of the 56 control subjects. Thus SAFA test is
more specifically related to existance of active intes-
tinal tuberculosis and differentiates it from other
non-tuberculosis intestinal diseases.
Diagnosis of intestinal tuberculosis using enzyme immunoassay
J .p. GUPTA, A.K. JAIN, B.K. A G R A W A L
and Saroj GUPTA
Div Gastroenterol, Inst Med Sci, Banaras Hindu Univ, Varanasi-5, India
June 1985 Proceedings of 26th Annual Meeting 281
The diagnosis of intestinal tuberculosis often pre-
sents difficulties and many a t ime requires laparo-
tomy. As such, the usefulness of a sensitive serologi-
cal test in its diagnosis needs evaluation.
In the present study sera from 38 histologically
established cases of intestinal tuberculosis, 26 of pul-
monary tuberculosis (+ve control) and 20 healthy
subjects ( -ve control) were studied for the titres of
antibodies to PPD employing ELISA. The titres
were expressed in terms of optical density (O.D.).
Mean titre in intestinal tuberculosis was 0.282
(range 0.114 to 0.532), in +ve controls 0.536 (range
0.074 to 0.98) and in -ve controls 0.121 (range
0.062 to 0.149).
The diagnostic usefulness of the test (sensitivity)
was evaluated taking 100% specificity i.e. highest
value among the negative controls (0.149) as refer-
ence point. 84% of intestinal tuberculosis and 88%
+ve controls had diagnostic titres of 0.150 or more.
These findings suggest usefulness of antibody titre
to PPD in the diagnosis of tuberculosis. However,
further confirmation and its relationship with ac-
tivity of the disease remains to be established.
NK activities and N K (HNK-1 +) cells in familial polyposis coli
M. CHIBA
1st Dept Intern Med, Akita Univ Sch Med
Natural killer (NK) activities and NK cells were
studied in 14 patients with familial polyposis coli
(FPC). Peripheral blood lymphocytes (PBL) from
FPC showed normal cytotoxicities against K562,
P4788 derived from colon cancer, and Chang cells.
Lamina proprial lymphocytes (LPL) isolated from
the resected colons exhibited expected cytotoxicities
against K562 and Chang cells. NK cells identified by
HNK-1 monoclonal antibody were distributed
mostly in a normal range for PBL and were not con-
tradictary to those seen in the controls for LPL. As
these results were not modified by the time factor of
colectomy, it seems unlikely that the deficit or im-
pairment of NK activities is one of the backgrounds
for the development of adenomas and the malignant change in FPC.
Interferon production activity of regional lymphode lymphocytes in patients
with colo-rectal cancer
M. SASAKI, M. KONN, Y. YAMANAKA,
T. MORITA, T. HASHIZUME, K. NARA,
H. ODAGIRI , M. FUJII and
K. ONO
Dept Surg, Hirosaki Univ Sch Med,
Hirosaki, Japan
Accumulative evidences have demonstrated the
anti- tumor effects of interferon (IFN). This study
was undertaken to investigate the roles of regional
lymphnode lymphocytes (RLL) in host defence
against tumors by testing the IFN production
ability.
Materials and Methods: Mononuclear cells were
isolated from regional lymphnodes and peripheral
blood (PBL) by Ficoll-Isopaque density gradient
centrifugation. IFN was induced by in vitro culture
with PHA-P, OK-432 and various cultured cell
lines. Determination of IFN activity were performed
by the cytopatbic effect reduction in VSV chal-
lenged human WISH cells.
Results: Results are summarized as follows:
1) No correlation was observed between the IFN
production ability and clinical stages, and IFN was
still detected even in cases of advanced stages.
2) Two types were demonstrated in IFN produc-
tion pattern according to the difference of IFN in-
ducers. IFN induced by OK-432 showed almost the
same level in both RLL and PBL.
3) IFN level induced by PHA-P was significantly
higher in RLL as compared with PBL. On the con-
trary, IFN induced by K562, HL-1 and HL-2 (lym-
phoblastoid cell lines) were significantly higher in
PBL than in RLL. This might be due to the fact
that NK cells are quite few in regional lymphnodes.
Thus, it was suggested that the function of RLL and
PBL was different in immune responses.
Immunological defense of gut-associated lymphoid tissue in gastrointestinal
malignancies
Y. NIO, T. TSUCHITANI , T. INAMOTO,
H. KODAMA and T. TOBE
282 Proceedings of26thAnnuaIMeeting Vol. 20, No. 3
Dept Surg, Univ of Kyoto Med Sch, Kyoto, Japan
We studied the immune response of gut-as-
sociated lymphoid tissue (GALT), especially mesen-
teric lymph node (MLN) and Peyer's patch (PP), in
murine experimental cecal tumors, which were pre-
pared by the transplantation of tumor cells into the
cecal patch, using syngeneic tumor-host system
(BALB/c mouse-BAMC 1 fibrosarcoma, and DS
mouse-SC 42 mammary adenocarcinoma).
As immunological parameters, Natural Killer
(NK) activity, lymphoblastic response to PHA
(LBR) and mixed lymphocyte tumor reaction
(MLTR) in mice with these tumors were compared
with those in sham-operated mice.
In spleen cells, LBR was remarkably suppressed
from one week after transplantation, but NK ac-
tivity and M L T R increased between one and two
weeks, and then decreased three weeks after trans-
plantation. In MLN cells, moderate suppression of
LBR and slight decrease of NK activity were ob-
served one week after. M L T R was enhanced be-
tween one and two weeks, but decreased thereafter.
In PP cells, these parameters were only slightly influ-
enced by tumors.
To augment the ant i- tumor immunity of G A L T
in gastrointestinal malignancies, we administered
the sterptococcal preparat ion "OK-432" orally. In
mice with transplanted cecal tumor, LBR, NK ac-
tivity and M L T R were augmented in MLN cells, but
not in spleen cells, by oral administration of OK-
432. In PP cells only NK activity was increased. In
addition, tumor growth was suppressed. These re-
sults indicate oral administration of OK-432 aug-
ments the local anti- tumor immunity of G A L T and
may have favorable therapeutic effects in cancer
therapy.
Monoclonal ant ibodies derived human colorectaI cell l ine by hybr idoma
techn ique (pre l iminary report)
Z.R. SHI and Y.S. KIM*
Dept Med, 2nd A)~liated Hosp, Hunan Med Coll, Changsha, Hunan, China and *GI Res Lab, VA Med Cent and Dept Med,
Univ of California, San Francisco, CA 94121 USA
Two monoclonal antibodies, LsL14 and LsL123
derived by fusion of mouse myeloma cells with
spleen cells from mice immunized with a human
colorectal carcinoma cell line, Ls 174T is described.
Both LsL14 and LsL123 were identified as mouse
IgM (u, k). These antibodies, when reacted with 10
different cultured human cancer cell lines, includ-
ing colonic cancer, gastric cancer, melanoma, lung
cancer, pancreatic cancer, bladder cancer and a
human fibroblast cell line using enzyme immunoas-
say technique, showed that LsL123 only reacted to
Ls174T, and LsL14 reacted to both Ls 174T and a
gastric cancer cell line Hutu 80. Immunohisto-
chemical study showed that LsL123 and LsL14 posi-
tively reacted to colorectal adenocarcinoma tissue in
44.5 % and 55.6 % respectively by using indirect im-
munofluorescence technique. But they also cross
reacted to normal human colonic tissue on luminal
membrane of lower colonic crypt (60 % and 30 %) or
on goblet cell mucin (30% for LsL14). This result
indicated that these two monoclonal antibodies were
not specific to the surface antigen of human colorec-
tal adenocarcinoma cells.
Immunohistological studies in various bowel diseases using monoclonal
antibodies
H. YAMAOKA, K. NISHIYAMA, S. TAJIMA,
T. FUKUSHIMA and S. TSUCHIYA
2nd Dept Surg, Yokohama City Univ, Yokohama, Japan
Distribution of T lymphocyte subsets in various
bowel diseases was analysed in tissue sections using
monoclonal antibodies. Ulcerative colitis, Crohn's
disease, familial polyposis coli, adenomatous polyp,
colorectal carcinoma and non-involved colon during
colectomy for carcinoma were studied. Indirect en-
zyme immunoassay was performed. OKT3, OKT4,
OKT8 (Ortho Labs.; 1 in 25), Leu M2, Leu 10 and
HLA-DR (Becton-Dickinson; 1 in 25) were used as
the first layer, and goat IgG F (ab')2 anti-mouse
(IgG + IgM) labelled with horseradish peroxidase
(Tago; 1 in 25) was used as the second layer. In
June 1985 Proceedings of 26th Annual Meeting 283
ulcerative colitis, OKT4 + cells were predominantly
infiltrated into the mucous membrane. In Crohn's
disease, OKT8 + cells were dominant on the con-
trary. OKT4 + cells were dominant in familial poly-
posis coli, and in adenomatous polyp. OKT3 § cells
were abundant and OKT4+ cells were dominant
around colorectal cartinoma. The proportion of
OKT3 + cells was significantly increased in ulcera-
tive colitis and colorectal carcinoma respectively
(p<0.01) Likewise, that of OKT4 + cells was in-
creased in ulcerative colitis (p<0.05) and well differ-
entiated adenocarcinoma of colo-rectum (p<0.01).
In Crohn's disease, the proportion of OKT4 + cells
decreased (p<0.05) and OKT8 + cells increased
(p<0.01).
Significant difference was observed in the dis-
tribution of intestinal lymphocyte subpopulation of
the various diseases, especially in ulcerative colitis
and Crohn's disease.
Studies on colon antigens by monoclona l
an t i bod i e s - -The re la t ionship of
ulcerat ive colitis with
colon ant igens
K. KUROE, A. KIMURA and Y. SUWA
1st Dept Intern Med, Hirosaki Univ Sch Med, Hirosaki, Japan
Histopathological analysis of ulcerative colitis
(UC) tissue has shown numerous inflammatory
mucosal infiltrates consisting of lymphocytes and
plasma cells in the involved colon. These mononu-
clear cells might be responsible for complicated cell
interactions, autoimmune reactions to a ceratin
antigen, and eventually damaging colon epithelium
cells. Helper and suppressor T cells have important
roles in the regulation of immunologic responses,
and their imbalance produces autoimmune phe-
nomena. We have shown that con A induced sup-
pressor activities of colonic mucosal lymphocytes
and PBL in UC were significantly lower than those
in normal controls. It was then suggested that a spe-
cific colon antigen induced the autoimmune reac-
tions with the suppressor activity decreased. There-
fore, the colonic antigen which is capable of in-
ducing anti colon antibody and sensitized lympho-
cytes was analysed by a hybridoma technique. Two
kinds of monoclonal antibodies for human colon
antigens were produced. One was against the base-
ment membrane and a part of Iamina propria of
healthy colonic mucosa. It reacted specifically with
the colonic mucosa. The other was against secretory
granules in the goblet cells of healthy large and
small intestine and against mucin. A monoclonal
antibody for rat colon antigen was produced, and it
reacted specifically with the goblet cells of the rat
colon. The antigens were detected by these mono-
clonal antibodies. From the above results followings
were speculated. Antigen of the basement mem-
brane or goblet cells may induce the autoimmune
reactions; Colonic cells may be damaged by the sen-
sitized lymphocytes and /o r ADCC, or by an altered
local defence mechanism of mucus. The above
speculation is supported by the findings reported
that the lymphocytes are cytotoxic for colonic cells
and that the goblet cells are decreased in active stage
and increased in remission in UC.
Significance of mucus deplet ion of colon
goblet cells in u lcera t ive colitis
H. FURUKAWA* and T. MIYAKE**
*Dept Med, Otsu Red Cross Hosp, Otsu, **Dept Geriat, Univ of Kyoto,
Kyoto, Japan
The phenol-water extract of human fetal colon
(Broberger et al. 1959) was used by us as an antigen
of skin test in patients with ulcerative colitis (u.c.)
and showed high frequency in the delayed reaction.
The extract also produced delayed reaction in
guinea pigs experiments and the immune sera con-
tained precipitating antibody. Immunofluorescence
method with the antisera against the polysaccharide
fraction of the extract using human colon specimens
showed specific fluorescence in cytoplasm of goblet
cells. Therefore, autoantibodies of u.c. are against
the goblet cell mucus. Using the anti-mucus, anti-
SC and anti-IgA fluorescent antisera, we examined
the biopsy specimens of the patients. In u.c., even in
the normal parts, SC and IgA in lumen of the glands
were diminished. Moreover, in the diseased parts,
mucus depletion was noted. The border parts decide
284 Proceedings of 26thAnnualMeeting Vol. 20, No. 3
the fate of the disease. Mucus depletion is integral
characteristics of u.c. Mucus glycoproteins are one
of the most important defence factors and their de-
pletion lays the epithelia bare, thus realizing the in-
vasion of bacteria, lectin-like agents and food aller-
gens. It is not conclusive whether autoimmunity in
u.c. is primary or secondary. However, it plays one
of the important roles in mucus depletion.
Abnormalities of immunoregulatory T-cel l popula t ions in patients
wi th ulcera t ive colitis
M. WATANABE, T. YOSHIDA, S. AISO,
H. ASAKURA and M. TSUCHIYA
Dept Intern Mecl, Sch Med, Keio Univ, Tokyo, Japan
Circulatory T-cells were characterized in 42 pa-
tients with ulcerative colitis (UC) by a fluorescence
activated cell sorter (FACS), using monoclonal anti-
bodies to the cell surface antigens of suppres-
sor/cytotoxic T-cells (Anti-Leu-2a) and helper/ in-
ducer T-cells (Anti-Leu-3a). The population of
Leu-2a positive cells was decreased in patients with
active UC, while that of Leu-3a positive cells did not
show any remarkable change. Moreover, function of
circulating suppressor cell was revealed to be im-
paired in the patients by Con A-induced suppressor
T-cell function assay.
Also, we studied the cell surface characteristics of
thymus cells from UC patients who had undergone
thymectomy for association of thymic hyperplasia.
Although the control thymus consisted of 82-94 % of
cells reactive with Anti-Leu-2a and 90-95% of ceils
reactive with Anti-Leu-3a, both Leu-2a positive and
Leu-3a positive cells were decreased.
Next, the relationship between lymphocytophilic
autoantibodies and peripheral T-cell subsets was ex-
amined by cell sorting and double staining tech-
nique on a FACS. The lymphocytophilic antibodies
in patients with UC were demonstrated to be mainly
reactive with Lau-2a positive cells and also, they
were reactive with some populations of Leu-3a posi-
tive cells and non-helper, non-suppressor T cells.
The other factors that may influence the immuno-
regulatory system in UC patients will be also dis-
cussed.
Cytokine product ion capacity in
inflammatory bowel disease
M. MIURA and N. H I W A T A S H I
3rd Dept Intern Med, Tohoku Univ Sch Med, Sendai
Immunological impairment in inflammatory
bowel disease has been the title of a number of
papers. In the present study we investigated presence
or absence of impairment in cytokine production
from mononuclear cells in inflammatory bowel dis-
ease. In addition T cell subsets and Ia positive
monocytes were examined. The study subjects con-
sisted of 26 cases of Crohn's disease (CD) and 7 cases
of ulcerative colitis (UC). As the controls, healthy
donors (HD) matching age and sex were used. No
differences were seen between UC and HD in any of
the parameters examined. However, reduction in
interleukin 2 and interferon activities was noted in
CD. They can not be attributable to decreased num-
ber of T cells, because no significant differences
were seen in the number of T cells including subsets.
On the other hand, as to the interleukin 1 produc-
tion capacity no differences were seen between HD
and CD. These results suggest that some form of dys-
functions exist at the level of T cells in the peri-
pheral blood in CD.
A novel IgA protease f rom Clostridium sp. (M.O.-6), an isolate f rom fecal
flora of the pat ient with I .B .D. ,
capable of cleaving IgA1 and IgA2:A2m (1), but not
IgA2:A2m (2) para- proteins
Y. FUJIYAMA, K. KOBAYASHI, T. BAMBA,
S. HOSODA and Y. BENNO
Dept Med, Shiga Univ Med Sci, Otsu, Dept Pediatr, Sch Med, Univ of
Yamaguchi, Ube, and Inst Physical and Chem Res,
Wako, Japan
In the course of our study examining the produci-
June 1985 Proceedings of 26th Annual Meeting 285
hility of IgA1 protease in the members of intestinal flora from patients with I.B.D.s to evaluate it's viruluency in the pathogenesis of I.B.D., we found out a unique strain of genus Clostridium which pro-
duced endopeptidase capable of cleaving both human IgA1 and IgA2 paraproteins.
The treatment of both IgA1 and IgA2:A2m (1),
myeloma proteins with the culture filtrates of
Clostridiurn sp. (M. O.-6) resulted fragmentation of these proteins into 2 fragments compatible to Fab and Fc on immunoelectrophoretic analysis. The MW of Fc fragment of IgA1 determined by SDS polyacrylamide gel electrophoresis was larger than
the Fc fragments obtained by the treatment with IgA1 proteases from previously reported bacterial strains. N-terminal aminoacids of Fc fragments ob- tained from both IgA1 and IgA2:A2m (1)were con- sisted of Valine. IgA2:A2m (2) paraproteins and also IgG, albumin, bovine serum albumin showed resistence to this endopeptidase.
These data are suggesting that the cleavage site of this novel endopeptidase from Clostridium sp. (M.O.-6) is within the homologous aminoacid se-
quence (221-222) lying in the hinge region of both IgA1 and IgA2:A2m (1) heavy chains.
Experimental inflammatory bowel disease in mice
Y. WAKASHIN, M. WAKASHIN, T. MORI, S. UEDA, H. YOSHIDA, Y. MORI
and K. OKUDA
Dept Med, Univ of Chiba, Chiba, Japan
It has been suggested that immunological mecha- nisms are involved in the etiology of inflammatory bowel disease (IBD), but the evidence is inadequate. In this study, we aimed to produce an experimental IBD model in mice, by injection of anti-colon anti- body, rabbit IgG sensitized T cells, and/or colon antigen sensitized T cells, and the relation of patho- logical lesions to cellular immunity was determined.
In group 1, 70 BALB/c mice were injected with anti-colon rabbit IgG and rabbit IgG sensitized T
ceils, and in group 2, 20 BALB/c were injected with syngeneic colon antigen sensitized T cells. Colon
antigen was prepared from BALB/c mouse colon mucosa, after washing with saline, homogenization and trypsinization. Antiserum was prepared by im- munizing rabbits with 100 mg of colon antigen 3 times. T cells were obtained from lymphnodes of BALB/c mice sensitized with rabbit IgG, and colon antigen. Histology and circulating antibody were examined at various time intervals. In group 1, IBD occurred with a high incidence in 70% of examined
mice, and the changes included focal necrosis, infil- tration of mononuclear and polymorphonuclear cells in the lamina propria. And in group 2, changes
were noted in 60% of mice, and it was characterized by typical ulceration on one side of the colon with chronic inflammatory cells infiltration in the ulcer base. These pathological changes seem to be closely related to cellular immune reactions, especially colon antigen sensitized T cells.
Internat ional Free Paper Session (1): Moderators: N. M A D A N A G O P A L A N (India) and Tatsuro T A K I N O (Japan)
A study of antibody to liver-specific membrane lipoprotein (anti-LSP) in circulating immune complexes
of patients with liver diseases
Li YOU and Ye WEI-FA
Bethune Med Coll, Changchun, Jilin, China
To study the compositions of liver-specific anti-
gen-antibody in circulating immune complexes, we
have measured anti-LSP in circulating immune complexes in 62 patients with liver diseases with positive immune complexes (ICs) in their sera, com- bining solidphase radioimmunoassay to anti-LSP with PEG precipitation method and glucine buffer separation method. To confirm the specific results, we have established competitive inhibition group be- sides standard control group during measurement. 5 of 8 patients with acute hepatitis are ICs-anti-LSP positive, 23 of 26 with chronic hepatitis and 20 of 28
286 Proceedings of 26thAnnualMeeting Vol. 20, No. 3
with cirrhosis are positive. There is no statistic
difference between HBsAg (+) group and HBsAg
( - ) group. Our result suggests tha t there is LSP-
anti-LSP complex in ICs of patients with liver dis-
eases.
The function of pituitary adrenal axis in hepatic cirrhosis
Guang-Xao YANG and Wei-Fa YE
Dept Med, Bethune Med Coil, Changchun, Jilin, People's Republ of China
To study the funct ion of pi tui tary adrenal axis, we
observed the rhy thmic secretion of adrenocort ico-
sterol day and night , and the response of p lasma
corticosterol to external ACTH and dexamethason
in patients with decompensated hepatic cirrhosis
(n=21). The rhy thmic secretion of corticosterol was
present, but the level of plasma corticosterol at 8:00
a .m. was lower in the cirrhosis group than that in
the normal control group (8.64 + 4.21 vs 14.9 •
4.96 g g % , p<0.01) . The response peak of p lasma
corticosterol appeared 8 hours after ACTH adminis-
t ra t ion in the control group, whereas it was not pre-
sent unti l after 16 hours after ACTH adminis t ra t ion
in the cirrhosis group. Th e response peak values to
ACTH was also reduced in the cirrhosis group
(21.02 • 8.41 vs 35.84 • 9 . 7 4 / / g % , p<0.05) . Four
of the ten pat ients examined, desamethason escaped
the inhibi tory effect of dexamethason on cortico-
sterol secretion. The da ta suggest tha t funct ional
disorder of pi tui tary adrena l axis be present in pa-
tients with cirrhosis. We conclude that it results
from decreased funct ion of adrenocortex and defect
of hormonal degrada t ion in patients with cirrhosis.
Local aspects of hepatic infections and impaired liver function
R.H.H. N E L W A N
Div Tropical and Infec Dis, Dept Med, Fac Med, Univ of lndonesia Dr.
cipto Mangunkusumo Hosp, Jakarta, Indonesia
As developing countries are struggling to improve
their s tandard of living, serious problems are some-
times encountered in heal th care. One of the prob-
lems that has to be faced with in Indonesia is the
high risk of liver infections and impai red liver func-
tion.
Liver impa i rmen t on the other h a n d calls for
more proper drug prescript ion habits. Many drugs
may affect the liver in a harmful way if not used
judiciously.
The wide spread use of local herbal medicine tha t
also may conta in hepatotoxic substances seems also
to contr ibute to the impa i rmen t of the normal liver
funct ion in our populat ion.
An accepted belief tha t only hepati t is B infections
are associated with hospital cross infections was
proven not to be the case. A case will be presented
on the occurrence of hepati t is A infection in a hospi-
talized pat ient and the hypothetical mode of trans-
mission.
Cell Mediated Immunity in amoebic l ive r abscess
B.M. GANDHI , H. GUPTA, M. IRSHAD,
T.C. C H A W L A and B.N. T A N D O N
Dept Gastroenterol, AIIMS, N. Delhi, India
Pathogenesis of invasive amoebiasis remains un-
known. Present study was under taken to study the
cellular i m m u n e response by leucocyte migra t ion in-
hibi t ion and count ing of pr imary effector cells i.e.
thymus derived (T) cells and bone mar row derived
(B) cells in 26 pat ients of amoebic liver abscess
(ALA) and compared with tha t of non-invasive in-
fections viz. 11 cyst passers, in 2 pat ients of acute
amoebic dysentry and in 3 pat ients of hepat ic
amoebiasis. 20 heal thy controls were also included
in the study. The study in ALA was repeated after
t rea tment and clinical recovery. A positive response
of LMI was ob ta ined in 16/26 acute ALA, whereas
9 /20 after recovery. No response was found in other
groups.
Results of the present study show a t ransient state
of immunodepress ion in patients of ALA as ob-
served by significant decrease in n u m b e r of T-active
(P<.001) and T- to ta l cells (P<.01) in ALA before
and after the recovery, however no significant differ-
June 1985 Proceedings of 26th Annual Meeting 287
ence was found in other groups. It thereby may help
E, histolytica to evade the defence mechanism of the
host to invade target cells and produce liver abscess.
The immune response was reversed after treatment
and clinical recovery in ALA.
Tc-99m DISIDA scintigraphic studies in the diagnosis of hepatobiliary
diseases
Mong CHO and Bang-Hyun LIU
Dept Intern Med, Coll Med, Pusan Natl
Univ, Pusan, Korea
For evaluation of the diagnostic value and useful-
ness of the Tc-99m DISIDA in the hepatobiliary dis-
eases, the hepatobiliary scintigraphy was performed
in 76 patients and 25 normal subjects at Pusan
National University Hospital during the period from
March 1983 to January 1984.
In ten cases of chronic cholecystitis, they showed
delayed visualization of the GB in two cases, and de-
layed biliary to bowel transit times in other two
cases.
In nine cases of partial biliary obstruction, they
showed none of the hepatobiliary elements but he-
patic uptake in two cases, and delayed visualization
of duodenum till 120 minutes in one case but nor-
mal scintigraphic finding in others.
In ten cases of hepatoma, the visualization of
hepatobiliary elements were dependent on size, loca-
tion and involvement of the regional lymph nodes.
The common hepatic duct, common bile duct,
GB, and duodenum were clearly visible in the cases
of serum bilirubin level showing less than 15 mg/d l ,
and also even visible in the case of chronic active
hepatitis showing 25 mg /d l serum bilirubin.
Conclusively Tc-99m DISIDA scintigraphy was
helpful in the diagnosis of cholecystitis, partial bili-
ary obstruction, and involvement of hepatobiliary
system of hepatoma.
Diagnostic value of fasting and post- prandial serum conjugated cholic
acid in chronic liver disease
Xie-ning WU Div Gastroenterol, Dept Med, Munic
1st People's Hosp, Shanghai, China
Fasting and postprandial serum conjugated cholic
acid (CCA) was studied by radioimmunoassay in 163
patients of various liver diseases and 97 healthy sub-
jects. Fatty meals of 55 and 88 gin gave similar re-
sults (p>0.05), the former was more tolerable in
Chinese. The mean fasting and postprandial CCA in
various diseases in increasing order were: CPH,
schistosomal cirrhosis, CAH, posthepatitic cirrhosis
and CAH cholestatic type. CPH vs healthy subjects
both were p<0.01; CPH vs CAH both p<0.001;
CPH vs schistosomal cirrhosis, fasting CCA p<0.01,
postprandial CCA p<0.001; posthepatitic cirrhosis
vs schistosomal cirrhosis fasting level p<0.01-0.05;
posthepatitic cirrhosis vs CAH both p<0.05-0.1.
Both fasting and postprandical CCA were 100%
positive in CAH and 93.3% and 85% respectively in
posthepatitic cirrhosis, much higher than other rou-
tine liver tests, whereas in CPH, they were not so.
Elevation of fasting CCA level could be categorized
into four grades: mild, moderate, conspicuous and
very conspicuous. Linear correlation was seen be-
tween fasting and postprandial CCA, but not with
other liver function tests. In conclusion: the sensi-
tivity of fasting and postprandial CCA varies with
different liver diseases, it is most sensitive and valu-
able in diagnosis of CAH and posthepatitic cirrho-
sis, but it can't replace the conventional liver tests in
CPH. To the authors' opinion, postprandial CCA is
not the most sensitive liver function test as advocated
by others.
Gallstones of intermediate cholesterol content in Northern India
Rakesh K. T A N D O N , A.K. SRIVASTAVA,
B.M.L. KAPUR and R.K. MISRA
Dept Gastroenterol, Surg ~ Biophysics,
All India Inst Med Sci, New Delhi, India
Of 152 consecutive gallstone patients operated at
our centre in Northern India, 122 (80.2%) were
found to have cholesterol gallstones (CS) and 10
(6.6%) pigment stones (PS), their individual choles-
terol contents being 70% and <20% of dry weight,
respectively. The remaining 20 (13.2%) patients
288 Proceedings of26th AnnualMeeting Vol. 20, No. 3
had stones with cholesterol contents in between 20
and 70% of dry weight and were therefore referred
to as gallstones of intermediate cholesterol content
(IS). Gallstones from 46 patients and bile samples
from 38 of them were analysed. The mean choles-
terol content of the stones (% dry weight) and the
cholesterol saturation index (CSI)of bile were 85.10
-+ 8.67 and 1.67 -+ 0.69 for CS, 6.07 + 3.57 and 0.83
_+ 0.35 for PS, and 48.10 _+ 17.92 and 2.54 _+ 1.24
for IS respectively. The CSI of control bile samples
was 0.97 _+ 0.30. Thus, CS as well as IS were asso-
ciated with bile supersaturated with cholesterol.
The lower cholesterol content of IS as compared
with CS was made up by a significantly higher con-
tent in IS of calcium, bilirubin, protein and muco-
polysaccharides. Samples of 5 IS were further
studied by X-ray diffraction, infra-red spectroscopy
and scanning electron microscopy. The findings sug-
gested that IS were cholesterol stones with an excess
deposition in them of non-cholesterol substances.
The large amount and the type of distribution of
calcium and pigment compounds in IS might be an
impediment to their dissolution by cholelitholytic
agents.
In ternat iona l Free Paper Session (2):
Modera to r s : B a n g - H y u n L I U (Korea) and Yoshio T A O K A (Japan)
Medical problems and their management in liver transplantation
Shi-huJIANG and Yan-zun LIN
Dept Med, Rui-jin Hosp, Shanghai 2nd Med Coll, Shanghai, China
Homologous orthotopic liver transplantation was
performed in six cases of hepatoma. Four medical
aspects concerned were: 1) selection and prepara-
tion of the patient. Internist should assure the tumor
confined only to the liver and a good coagulation
mechanism before surgery. 2) management of 'ahe-
patic phase'. Hemorrhagic diathesis due to lack of
factors VII, IX and X, increase of fibrinolysis and
heparin-like substances should be corrected by
PPSB, trasylol and protamine respectively. Meta-
bolic acidosis and hyperglycemia were frequent and
must be corrected. 3) management of graft rejec-
tion. Acute rejections occurred regularly on 4th-7th
day and 10th-15th day after operation, but irregu-
larly in subsequent attacks. There were a total of 32
such episodes, each time was well controlled with
bolus injection of methyl prednisolone. We found
sudden decrease of bile excretion a premonitory sign
of impending rejection. 4) management of compli-
cations of immunosuppression. Upper GI bleeding
occurred in first two cases but not in subsequent four
after giving prophylactic cimetidine. Opportunistic
bacterial infection could be controlled by antibio-
tics, but one case contracted acute fulminating HBV
hepatitis. All six recovered from surgery but sur-
vived 54 261 days only, averaged 156.7 days. Causes
of death were bleeding in one, acute hepatic failure
in one and recurrence of hepatoma in four. Our ex-
periences indicate patients with hepatoma are not
good candidates for liver transplantation.
Clinical and scintigraphic studies on id iopathic por ta l hypertension
in Korea
Bang-Hyun LIU
Dept Intern Med, Coll Mecl, Pusan Natl Univ, Pusan, Korea
Clinical & scintigraphic studies on 54 cases of IPH
were carried out at the Pusan University Hospital
between the period of 1962-1982.
They involved 29 males and 25 females.
Male:female ratio was 1.2:l . Majority cases
(63%) were found in younger age (between age
20-39).
Hematologically anemia, leukopenia and throm-
bocytopenia were significant but chemical liver
function abnormality was minimum.
On immunological studies he found HB Virus
markers in 4 cases out of 20 patients.
In this study the author found huge spleno-
megaly, portal hypertension and pancytopenia. His-
June 1985 Proceedings of 26th Annual Meeting 289
topathologically congestive changes and Gandy-
Gamma nodule (Fibroadenie) was also characteris-
tic in splenectomized spleen but hepatic dysfunction
was slight and minimal fibrosis was noticed on liver
biopsy. And on radiogold scintigram marked spleen
visualization was characteristic in all cases, however
no significant changes of hepatic figure and uptake.
Correlation between high portal pressure and
spleen visualization was significant and correlation
between spleen weight and spleen visualization also
noticed.
Sonography of portal venous system in
portal hypertension: Correlation with the size of oesophageal
varices
S.A. ABDURACHMAN and Sujono HADI
Div Gastroenterol, Dept Intern Med, Padjadjaran Univ Sch Med /Hasan
Sadikin Hosp, Bandung, Indonesia
Portal venous system was studied with sonography
in patients with endoscopically documented variceal
bleeding. Optimal scans were obtained in 60 pa-
tients.
Dilatation of the portal venous system may occur
in portal hypertension, and the diameter of portal,
splenic and superior mesenteric veins greater than
13 rnm, 10 mm and 8 mm respectively, were indica-
tive of portal hypertension with a sensitivity of 60 %,
74% and 55% respectively.
There was no significant relationship between the
variceal size and the diameter of portal, splenic and
superior mesenteric veins, although larger varices
seem to be associated with a wider portal venous sys-
tem.
It is concluded that in patients with UGI bleed-
ing, UGI endoscopy should be followed by sono-
graphy of the portal system. Variceal bleeding will
be demonstrated by endoscopy, while sonography is
a valuable screening procedure in the evaluation of
portal hypertension and provides valuable informa-
tion regarding the caliber and patency of the portal
venous system.
Endoscopic sclerotherapy (EST) in the
long term: Management of portal
hypertension
D.K. BHARGAVA
Dept Gastroenterol, All India Inst Med Sci, New Delhi, India
The repeated EST procedures at intervals has
been undertaken to evaluate its value in prevention
of recurrent bleeding and eradication of varices.
82 patients with an underlying cirrhosis in 51 and
noncirrhotic diseases in 31 were included in the
study. Polidocanol 1% was injected intravariceally
at an interval of 3 weeks till the varices were obliter-
ated. The patients were followed from 2 to 34 mth
with an average duration prior to EST was 11.43
and post EST follow up was of 10.88 mths. Alto-
gether prior to EST there were 204 episodes of
bleeding & 681 units of blood were transfused. In
contrast in post EST period they have 48 episodes of
bleeding and 70 units of blood was needed. Recur-
rent bleeding after EST was more in cirrhotic than
non cirrhotic group and majority of them were seen
prior to 6 EST injections. The varices disappeared
in 40 (74%) out of 54 patients. 28 patients are still
early for analysis. None of them bled after eradica-
tion of varices. In 2, varices reappeared after 12 and
16 mths. 6 (7.3%) patients had complications as
stricture and ulcer. 14 (28%) patients died among
50 patients classified as child's B and C. 10 of them
were cirrhotic. It is difficult to comment on quanti-
tative survival. Thus EST has decreased recurrent
bleeding and need of blood transfusion thereby
quality of life improved. Varices can be obliterated
in majority of patients.
Modified injection sclerotherapy of esophageal varices
B.K. A G R A W A L and K.R. BHAT
Dept Med, Kasturba Hosp, Manipal, India
A prospective randomised study comparing the
efficacy of intravariceal injection sclerotherapy with
or without propranolol administration was done in
27 consecutive pts. (20 cirrhosis, 2 NCPF, 6 portal
vein obstruction) in whom initial active variceal
290 Proceedings of 26th Annual Meeting Vol. 20, No. 3
bleeding was controlled by conservative methods.
Oral propranolol was given in the dose to reduce the
resting pulse rate by 25%. The two groups (14 with
& 13 without propranolol) did not differ in age, sex,
cause of portal hypertension, Child's grade or grade
of varices significantly. Intravariceal sclerotherapy
was done with Olympus GIF-Qscope and flexible in-
jection cannula using 1% Aethoxysklerol. Injections
were repeated at interval of 1 to 3 weeks till the
varices were obliterated.
The recurrence of bleeding within first 24 hours
was significantly low in the propranolol treated
group than in the control group. The number of
courses of injections required to obliterate the
varices in the propranolol treated group was also sig-
nificantly less than that in the control group.
Concl.: Intravariceal sclerotherapy in patients
pretreated with propranolol leads to early oblitera-
tion of varices & also reduces risk of early rebleed-
ing.
method, the mortality was 33%. After 1977, herbs
have been used in combination with the conven-
tional western treatment. A Sengstaken tube is
passed routinely for temponade. Herbal mixture
compounded of Rheum and Bletilla striata is intro-
duced into the stomach through the gastric tube re-
gularly at intervals of 2-4 hours. If bleeding is not
stopped, patient is given a paste of Rheum and
Panax orally, and then the esophageal baloon is in-
flated to compress the esophageal wall with the paste
in between. As shown in the table, the mortality rate
has been reduced to about 11-14% in the recent
years. The incidence of post-hemorrhagic coma has
been markedly lowered. Plasma fibrinogen and pro-
thrombin were increased in galactosamine intoxi-
cated rats when treated with Rheum in contrast to
the untreated control.
Death Death Cases Mortality due to due to
shock come
Combined treatment of esophageal varices Western bleeding with western and Chinese treatment
1973-77.6 183 61 (33%) 25 (13.7%) 31 (16.9%) herbal medicine in cirrhotics Combined
Wang BAOEN, et al. treatment 1977-79 89 13 (14.6%) 7(7 .8%) 3 (3 .3%)
Dept Med, Beijing Friendship Hosp, 1980 52 6 (11.5%) 5 (9.6%) 1 (1 .9%) Beijing, China 1981 46 6(13.7%) 4 (8 .7%) 2 (4 .9%)
1982 58 8 (13.7%) 5 (8 .5%) 0 Bebore 1977, we treated massive esophageal p<0.01 p<0.05 p<0.01
bleeding in cirrhotics with the conventional western
I n te rna t i o na l Free Paper Session (3):
Modera to r s : M. P A N C H A N A D A M (India) a n d Shi ro S U Z U K I (Japan)
Clinical spectrum and surgical relief of chronic obstruction of hepatic and suprahepatic segment of inferior vena cava (IVC)--
10 year survey
N. MADANAGOPALAN, V. SOLOMON,
V. JAYANTHI , K. RAGHURAM,
I. KANDASAMY, S. A N N A P O O R A N I ,
A. GAJARAI and M. PANCHANADAM
Dept Gastroenterol, Thoracic Surg, Barnard
Inst Radio ~ Inst Pathol, Madras Med Coil ~ Govt Gen Hosp,
Madras, India
Clinical spectrum, etiopathology, hepatic outflow
and IVC-gram studies in 50 patients with chronic
hepatic and suprahepatic segment obstruction of
IVC with or without hepatic vein (HV) obstruction
seen in 10 years, will be described. Hepatocellular
carcinoma was a common cause of hepatic vein ob-
struction with IVC involvement, but possible throm-
June 1985 Proceedings of 26th Annual Meeting 291
bosis of long segment of hepatic segment of IVC
with or without HV involvement and hour glass con-
striction of IVC just above the drainage of HVs were
also encountered. Such hour glass constriction high
in IVC similar to coarctation of aorta, was observed
in 15. The appearances even suggest a designation
of 'coarctation of IVC. ' Some patients in whom early
surgical repair could have been rewarding presented
after advent of ascites and features of decompen-
sated cirrhosis, making surgery too risky. Even then,
surgery was possible in 10 with such hour glass con-
striction, who presented all features of chronic
Budd-Chiari syndrome. The surgical procedures
used were retro-hepatic cavocaval or cavo-atrial
bypass, using either aortic homograft (3 cases),
plain or ringed P.T.F.E. (Goretex) graft in 6. In one
patient, 'isthmusplasty,' a novel step, offered excel-
lent relief. Special mention will be made of observ-
ance of indisputable histopathological features of
chronic active hepatitis in some with chronic Budd-
Chiari syndrome.
Non-A non-B hepatitis: A health problem in India
Y.K. JOSHI, B.M. GANDHI and
B.N. T A N D O N
Dept Gastroenterol, AIIMS, New Delhi
Non-A non-B (NANB) hepatitis is common dis-
ease in India. Studies at our center have shown that
about 50% of sporadic AVH in adults and 20% in
children is due to NANB infection. Similarly half of
the cases of fulminant hepatic failure and subacute
hepatic failure are due to this infection. Chronic se-
quelae have been observed in 2% of the sporadic
NANB hepatitis. 11 of the 12 epidemics of jaundice
studied by us were due to NANB hepatitis. Disease
predominantely affected the adult population and
had a moderately severe course. No chronic sequelae
has been recorded in one year follow up of the pa-
tients from one of these epidemics. 80% cases of
sporadic NANB hepatitis are suggested to be due to
fecal-oral transmission. Only 15% gave history of
parenteral exposure and 5% had close contact with
jaundiced patients. All the epidemics were water
borne for following reasons. 1) Involvement of large
areas and population. 2) Absence of sewage disposal
system. 3) Improper and inadequate chlorination of
water. 4) Fecal contamination of water. 5) Control
of the epidemic after proper chlorination and other
measures of public hygiene.
These findings are important to plan out the mea-
sures for control of hepatitis in India. Following
measures may prove helpful to reduce the incidence
of NANB hepatitis. 1) Prevention of water con-
tamination with fecal material , 2) Safe water supply
and 3) Health education on personal and environ-
mental hygiene.
The prevalence of non A non B acute
viral hepatitis in Dr. Soetomo
Hospital Surabaya
A. HASSAN, H. GUNTUR, R. SOEMARTO,
S.H. RAHARDJA and W. SOEMARTO
Div Hepato-Gastroenterol, Dept Med, Airlangga Univ, Sch Med,
Surabaya, Indonesia
The aim of the study was to investigate the inci-
dence and the clinical features of patients with non
A, non B acute viral hepatitis.
The diagnosis of acute viral hepatitis A and B can
now be established, because methods for detection
of HAV and HBV markers are now available.
HBsAg was determined by RPHA, while IgM anti-
HAV and anti-HBc by RIA. At present the diagno-
sis of non A non B hepatitis can be made only in-
directly by exclusion of HAV and HBV.
Out of the 108 cases of acute viral hepatitis in Dr.
Soetomo Hospital, 49 cases (39.8%) were HA, 28
cases (25.9%) were HB and 37 cases (34.2%) were
non A non B hepatitis. Of the 9 cases of post-trans-
fusion hepatitis there was only 1 case (11.1%) of HB
and the other 8 cases (88.9%) were non A non B he-
patitis. No HA was found in all 9 PTH cases.
Cl in ica l and immunolog ica l observation on the multisystem manifestations
of chronic hepatitis
Wang BAOEN, et al.
Dept Med, beijing Friendship Hosp, Beijing, China
292 Proceedings of26th Annual Meeting Vol. 20. No. 3
942 cases of chronic hepatitis have been observed
in the past five years. Among them, 126 cases
(13.4%) showed extrahepatic muhisystem mani-
festations. They were: 1) High fever, lasting from
several months to a year. 2 )Jo in t and muscle in-
volvement, including 75 cases (59.5%) of arthralgia
and arthritis, 44 cases (34.9%) of muscular pain. 3)
Skin lesions, showing macropapil lary rashes, urti-
caria, purpura and longstanding itching. 4) Cardiac
and pulmonary lesions consisting of A-V block
(I~176 myocardial damage and interstitial
pneumonitis. 5) Nephritic lesions. 6) Hematologi-
cally, anemia, leukopenia, thrombocytopenia and
aplastic anemia. 7) Beh~et's disease and Sj6gren's
syndrome. Immunological studies showed there was
no difference in incidence of extrahepatic mani-
festations between HBsAg positive and negative
cases.
Serum immune complex detected with methods of
HBsAg specific I.C., PEG, total serum complement
and C3, was positive in 50% of the cases. This sug-
gests that immune complex formation may be in-
volved in the pathogenesis. Immunoglobulins were
elevated, while autoimmune antibodies and cellular
immunity showed no marked change.
Comparat ive studies on HBV markers detection by radioimmunoassay,
RPHA, EIA and C I E P technique
in var ious l iver diseases
Keun-Soo PARK and Bang-Hyun LIU
Dept Intern Med, Coil Med, Pusan Natl Univ, Pusan, Korea
Sera from patients with various liver diseases,
visited to Pusan National University Hospital, from
March, 1977 to June, 1983, were examined for HBV
markers by RIA, RPHA, EIA and CIEP technique.
The results were as follows:
1. HBsAg:
Group with acute hepatitis revealed significant
difference in sensitivity in order of RIA, RPHA and
CIEP. Group with chronic hepatitis showed signifi-
cant difference between CIEP and RPHA, and be-
tween CIEP and RIA, but no significant difference
between RPHA and RIA technique.
In patients with liver cirrhosis, RIA was sensitive
significantly than RPHA, but in hepatoma, there
was no significant difference.
2. Anti-HBs:
Generally RIA revealed higher incidence than
RPHA, but RIA showed significant difference than
RPHA only in group with chronic hepatitis.
3. Other markers:
In group with acute hepatitis, EIA and RIA
showed significant difference for detection of
HBeAg and no significant difference for detection of
Anti-HBc.
HBsAg-associated albumin receptor
in sera of patients with
v i ra l hepatit is
G.B. YAO, L.M. ZHANG, M.F. WU,
S.T. T O N G and Y.F. T I A N
Chn Immunol Res Unit,Jing'an Centr District Hosp, Shanghai, China
The receptor for polymerized human serum albu-
min (PHSA) was studied by hemagglutination
method in 125 cases with viral hepatitis. The geo-
metric mean titer (GMT) of PHSA binding activity
in 50 normal controls was 2.0 + 1.9, and in 50 cases
of acute viral hepatitis A was 4.4 ___ 2.2 (p<0.05).
The GMT titers of PHSA binding in patients with
various HBV infection were as follows: acute hepati-
tis (10) 16.0 _ 7.5, chronic persistent hepatitis (30)
66.6 __ 6.2, chronic active hepatitis (10) 149.4 + 1.7,
chronic asymptomatic carrier (10) 53.8 + 3.2 and
posthepatitis cirrhosis (8) 10.3 _+ 2.7. The correla-
tion coefficient between the PHSA binding GMT
and HBsAg GMT (RPHA) in HBsAg positive sera
was 0.68 (p<0.01). The correlation between PHSA
and HBsAg GMT in cases with HBeAg positive was
also highly significant (r=0.77, p<0.01). The GMT
of PHSA binding activity in 16 cases with HBeAg
positive was 261.8 _ 3.1, and in 58 cases with
HBeAg negative (HBsAg positive) was 20.5 • 5.0
(p<0.01). This study suggests that HBsAg-associated
PHSA receptor may represent a new and useful
virus-associated marker in HBV infection.
June 1985 Proceedings of 26th Annual Meeting 293
I n terna t i o na l Free Paper Session (4):
Modera to r s : W a n g B A O E N (Ch ina ) a n d Kei ichi K A W A I ( Japan)
The action of gastrin, secretin and prostaglandin F2a on lower eso- phageal sphincter after Nissen
fundopl ica t ion in dog
N. IWAI, H. KANEDA, T. TSUTO,
J. YANAGIHARA and T. TAKAHASHI
Div Surg, Kyoto Pref Univ Med, Kyoto, Japan
This study was done to investigate the action of
gastrin, secretin and prostaglandin on the antireflux
mechanism of the gastroesophageal junction after
Nissen fundoplication.
Nissen fundoplication was performed in 27 mon-
grel dogs under general anesthesia. Esophageal
manometry was done preoperatively, intraopera-
tively, and 2, 4, and 8 weeks after operation.
The injection of 4 r /kg of pentagastrin signifi-
cantly raised the LES pressure both preoperatively
and 8 weeks postoperatively. The LES pressure after
gastrin stimulation increased from 38.1 + 3.5
cmH20 before the operation to 65.0 _+ 8.5 cmH20 2
weeks after operation (P<0.005). However, no sig-
nificant changes occurred in LES length before and
after gastrin stimulation. The injection of 1.5
r / k g / m i n of prostaglandin F2c~ raised significantly
the LES pressure preoperatively. However, the LES
pressure after prostaglandin stimulation did not in-
crease from preoperatively (33.7 + 3,6 cmH20) to 2
weeks postoperatively (33.8 + 7.8 cmH20).
It seems that gastric stimulation to a new mus-
cular sphincter substitute is associated with the anti-
reflux mechanism.
Pyloric sphincter pressure measured with miniature transducer under
fiber-gastroscopy
ZhangJINKUN, et al.
Dept Med, 1st Hosp, Wuhan Med Coil, Wuhan, China
Pyloric sphincter pressure (PSP) was assessed with
a sensitive miniature transducer under gastroscopy.
The mean amplitude of the pyloric high pressure
zone was 21.8 _+ 1.3 m m H g in 50 normal Chinese
adults. The PSP of chronic gastritis (30), peptic
ulcer (38) and gastric carcinoma (6) was diminished,
and those diseases were also found to have pyloric
dysfunction. This data not only present the patho-
physiology and clinical menifestations, but also help
to choose the effective drugs for the treatment. Fur-
thermore, if the PSP 10 m m H g in duodenal ulcer, it
suggests that the protective reflux function of
pylorus is lost.
Carcinoma of gastric stump in China
ZhangJINKUN, et al.
Dept Endos, China Natl Co-operative Group gast Cancer, Wuhan Med
Coil, Wuhan, China
51 cases of gastric stump carcinoma were col-
lected from 18 hospitals throughout China during
the past 9.5 years. There were 47 males and 4 fe-
males. 41 cases (73%) were over 50 years old. The
primary preceding diseases were: gastric ulcer 31,
duodenal ulcer 17 and benign gastric lesion 3 cases.
The types of previous operation were Billorth II 29,
Billorth I 7 and indeterminate 15. The mean inter-
val from the operation to the diagnosis of cancer was
13.8 years. 88% of the present series had a definite
diagnosis by the fibergastroscopy and biopsy. The
rest of the cases were diagnosed by the postoperative
pathologic examination. The X-ray examination
was positive in only 19% of cases. The location of
the cancer was at the anastomotic stoma 45 %, in the
body of stump 36% and in the fundus 19%.
Local irritation following the anastomosis was
considered as a possible cause of malignant trans-
formation. Meticulous care in suturing and the
proper use of resorbable suture material may help
reduce the development of this cancer.
Prevelance of gastric cancer in
294 Proceedings of 26thAnnualMeeting Vol. 20, No. 3
Kashmir natives
Hamid A. DURRANI
GI Div, Dept Med, Med CoU, Srinagar, Kashmir, India
Gastric cancer ranks next only to esophageal can-
cer as a common cause of mortality in the native
population of Kashmir valley in the mountains of
north-west India. The incidence is strikingly high
when compared to other population groups in this
country.
The study is a comprehensive analysis of 850 cases
diagnosed in the last five years at one teaching-cum-
referral center. 82% cases were males and 18% fe-
males, 62% smokers and 38% nonsmokers, 60% of
the patients belonged to the age group 41-60 years.
Endoscopic appearances were classified as nodular
mass 47%, polypoid mass 20%, malignant ulcer
10%, infilterative lesion 8%, rounded tumor mass
8%, linitis plastica 5% and early gastric cancer 2%.
On histopathological typing 79% lesions were
adenocarcinomas, 8% mucoid carcinomas, 8%
leimyosarcomas, 4% schirrous carcinomas, and 1%
reticulum cell sarcomas.
The possible etiological factors peculiar to the
dietary constituents are singled out. Genetic factors
may have an important role in the etiology of gastric
cancer in this high risk group.
Small bowel changes in chyluria
J.P. GUPTA, A.K. JAIN, A.K. GOVIL
and V.N.P. T R I P A T H I
Div Gastroenterol, Inst Med Sci, Banaras Hindu Univ, Varanasi-5, India
Chyluria is one of the common manifestations of
filariasis. Although there is retroperitoneal lymph-
angiectasia with lymphatic varices in chyluria, the
involvement of intestinal lymphatics and its adverse
effects on intestinal structure and function remain
unknown.
Sixteen subjects of chyluria (urine +ve for chyle)
with repeated stool examination negative for ova
and cyst were studied. In them urinary excretion of
d-xylose, faecal fat excretion, gastrointestinal (GI)
protein loss (using RIHSA), serum proteins with
A:G ratio and lipidograms were done. Barium con-
trast jejunal radiography and jejunal biopsies were
also studied. The majority (88%) had no GI symptoms. Serum
lipid profile and faecal fat excretion were normal in
all. Three fourth subjects had reduced serum albu-
min with normal globulins. RIHSA studies revealed
decreased half life in chylurias compared to con-
trols. Jejunal biopsy showed marked to moderate
lymphangiectasia in three fourths with grade II to
grade III villous changes in 40%.
Thus, although varying degree of intestinal lym-
phangiectasia was present in the majority of chylu-
rics and was associated with villous changes in more
than third but biochemical evidence of malabsorp-
tion was absent.
Cl in ica l appl icat ion of "Purgation Method" in t reat ing digestive
diseases and its mechanism
Wang BAOEN, et al.
Dept Med, Beijing Friendship Hosp
"Purgation method" of Chinese traditional medi-
cine has been used in combination with western
medicine in treating digestive diseases, such as acute
pancreatitis, cholecystitis, liver abscess, bacillary
dysentery and upper G-I bleeding. Good clinical re-
sult was observed, especially in regard to the subsi-
dence of fever and reduction of toxic symptoms.
Animal experiment showed that the antipyretic
effect is at tr ibuted to the chief component of the
purgative mixture, Rhubarb. Further experiment
revealed that rhubarb could significantly reduce the
activity of prostaglandin E in the C.S.F. drained
from the third ventricle near the thermoregulation
center (P<0.001). The lowering of anal temperature
is proportionally correlated to the reduction of PGE
in the C.S.F. (r=0.72, P<0.01). The purgative mix-
ture also increases the phagocytic function of PMN
and the activity of total serum complement. It can
also counter-act endotoxin in the blood. The hemo-
static effect is due to the local effect of Rheum as
well as some change of the coagulation factor.
Alteration in human colonic muc in
June 1985 Proceedings of 26th Annual Meeting 295
b i n d i n g to the lectins in the diagnosis of colonic
adenocarcinoma
Z.R. SHI, D.Y. YIN and F.Q. WEN
Dept Med, 2nd Aj~liated Hosp, Hunan Med Coll, Changsha, China
Changes in the pa t te rn of colonic mucin secretion
has been described in colon cancer. In this study,
the b ind ing of F ITC-PNA (peanut agglut inin) and
FITC-DBA (dolichos biflorus agglut inin) to the
muc in in the colorectal ca rc inoma (Ca), t ransi t ional
mucosa (Tin), normal colonic mucosa (Nm), adeno-
matous polyps (Ap), villous adenomas (Va) and
mult iple adenomas (Ma) were studied by using fluo-
rescence microscopy. The b ind ing capacity was
scored as 0, no; 1+ weak; 2+ modera te ; 3+ strong
fluorescence. The result is listed on Tab le 1.
Table 1. Bindingof FITC-PNA and FITC-DBA to different kind of colonic mucosa
Ca Tm Nm Ap Va Ma n=25 n=25 n=25 n=20 n=10 n=5
1+ 8 2+ 3 1+ 5 0 4 1+ 5 2+11 3+ 22 2+ 3 1+ 4 3+ 6 3+ 12 2+ 2 0 12 0 25 0 20 0 2 0 4 1+ 8 1+ 3 1+ 1 2+ 5 2+ 5
DBA 0 18 1+ 4 2+ 3
PNA 1+ 3 2+ 8 3+ 14
An exposed carbohydra te s t ructure in the secreted
mucin was found in h u m a n colonic carc inoma
which was not present in no rma l colonic mucosa. It
may be of benefit for the diagnosis of colorectal car-
c inoma.
Direct vision of the pancreas wi th
laparoscope
J inkun ZHANG
Dept Med, 1st Hosp, Wuhan Med Coil, Wuhan, China
We, with supragastr ic approach th rough the
lesser omentum, inserted the endoscope into the
lesser peri toneal sac for direct vision of the pancreas.
Twelve cases were examined and ten of them were
successfully done. T h e diagnoses were: Three nor-
mal , four chronic pancreat i t is , one pseudocyst, one
cancer of pancreat ic body and one cancer of pancre-
atic head. All diagnoses were supported by the
ERCP, B-type ul t rasonography, and BT-PABA test,
etc.
This paper discusses the endoscopic technique for
direct vision of the pancreas and how to perform the
laparoscopic examina t ion with the GIFP3 and its
accessories such as cold l ight supply, biopsy forceps
with UES generatory and photography.
In terna t iona l Free Paper Session (5):
M o d e r a t o r s : D i n g - S h i n n C H E N ( T a i w a n ) a n d Yasuo E N D O ( J a p a n )
Correlated c l in ica l , h i s topa tho log ica l ,
HBV and AFP studies in primary carcinoma liver and speculations
on possible additional role of non -ed ib l e oi l i n
pa thogenes is
M, PANCHANADAM, V.C. BALASUBRAMANIA,
P. SARE, S.P. THYAGARAJAN,
S. MAHADEVAN and S. D R A V I D A M A N I
Inst Pathol, Microbiol and Animal Experimental La b, Madras Med
Coll, Madras-3, India
This paper presents clinical and histopathological
features of over 300 cases of p r imary liver cancer
over last 14 yrs. This large n u m b e r suggests increas-
ing prevalence in last 2 decades. Special features
are, a) 40% are below age 40, b) 75% have sympto-
mat ic illness <6 too, c) large propor t ion are non-
alcoholic. The initial HBsAg (+) was 31%, but it in-
creased to 60% with ELISA. AFP was <200 n g / m l
in 20% of those who were (+). Ground nut oil was
the ma in cooking oil in most patients. It became es-
296 Proceedings of26th Annual Meeting Vol. 20, No. 3
sential to explore possible role of con taminan t s and
adulterants of oils for the apparen t increase of HCC,
particularly the short dura t ion illness in younger age
group. The impor t an t change over last 2 decades
has been the shift from cattle operated rotaries for
ground nut oil extract ion to huge electric rotaries
which at times operate for extract ing nonedib le oils
such as cashew nut shell l iquid (CNSL). If potent ial-
ly toxic oil were to con tamina te edible oil, more so if
already rich in mycotoxins, and consumed by people
at high risk with HBV infection, it may speed up
evolution of HCC. Prel iminary studies in rats have
shown hepatic pa renchymay and bile duct changes,
and unusual f ibroadenoma breast, in animals fed
with ground oil mixed with minimal amounts of
CNSL. Animal studies with pure ground nut oil and
commercial oil mixed with CNSL will also be pre-
sented.
Primary hepato-cellular carcinoma
Pranesh NIGAM, A.K. A G R A W A L and
K.K. K A P O O R
Dept Med, BRD Med Coll, Gorakhpur-273013,
U.P., India
Fifteen patients (mean age=58.6 yrs, sex
ra t io=4 .5 : l ) were studied for the clinical profile. As-
sociated cirrhosis was seen in 5 males who deterio-
rated for no obvious reason. Usual presenta t ion of
malaise, abdomina l fullness, anorexia, const ipat ion
etc, was mainly seen. Dull acheing type of pain over
epigastrium, r ight upper quad ran t and back was
present in all of them which was severe in one case
with friction rub over epigastr ium. Mild to moder-
ate jaundice was seen with nodular ha rd liver. Left
lobe of liver was exclusively involved in 2 cases. Arte-
rial m u r m u r over r ight hypochondr ium was audible
in 4 cases. Ascites was present in 6 cases and ascitic
fluid revealed high prote in (4.6 gms%), lactic de-
hydrogenase (108 IU) and mal ignan t cells (3 cases).
Massive blood t inged r ight sided pleural effusion de-
veloped in a lady, and painful gynecomastia was
present in one case. Hypoglycemia (fasting 50 m g % ,
PP 90 m g % blood sugar) noted in 4 cases. Serum
cholestarol was raised (382 m g % ) in 3 cases, Serum
alk. phosphatase was markedly raised (102 IU) with
ra ised s e r u m t r a n s a m i n a s e s . Ery throcy tos i s
(Hb.=16.2 g ins%) was seen in one case. Histology
revealed smaller t umor cells resembling normal liver
cells with compact finger like processes or solid tra-
biculae. Max imum survival=l year.
Diagnostic value of fine needle aspiration: A prospective study
L. LESMANA, H. SIDHARTA,
W. M A R W O T O , N. AKBAR, A. SULAIMAN
and H.M. SJAIFOELLAH NOER
Dept Med and Anatomic Pathol Univ
o f Indonesia, Jakarta, Indonesia
This study was carr ied out to assess the accuracy
of fine needle aspirat ion (FNA) in focal hepat ic
lesion.
Dur ing an eight months period (August 1, 1983 to
April 30, 1984) FNA under ultrasonic guidance was
performed on 60 pts in whom US revealed a hypo or
hyperechoic lesion(s). A real t ime sector or l inear
scanning with a c o m m o n t ransducer were used for
this purpose. The aspirated mater ia l was stained ac-
cording to Papanico laou technique for cytological
examinat ion .
Results: Correct diagnosis of FNA was found in 53
of 60 pts (88.3%); 44 with liver cancer (LC) and 9
with abscess of the liver (AL). False negative diagno-
sis was ob ta ined in. 3 pts (5%) with pr imary LC. In-
conclusive diagnosis was found in 4 pts (6 .7%) one
pt proved to have secondary LC on liver biopsy, in 2
pts a follow-up US showed no growth of the lesion
and the r ema in ing one pt refused to undergo fur ther
examinat ions. Complicat ions were not noticed in
this study.
Conclusion: Fine needle aspirat ion is a safe
method and has a high diagnostic value in focal
hepatic lesion.
Serodiagnosis of hepatic neoplasia
J .P. G U P T A , B.V. T A N T R Y and
A . K . J A I N
Div Gastroenterol, Inst Med Sci, Banaras
Hindu Univ, Vanarasi-5, India
Serological diagnosis of tumors is a recent de-
June 1985 Proceedings of 26th Annual Meeting 297
velopment and has been used in various malig- nancies. Amongst various tests LAI (leukocyte ad- herence inhibition) is a reliable, rapid and simple
technique. In the present study, LAI test was done in patients
with established primary and secondary carcinomas of liver using specific primary and secondary liver carcinoma antigens. Six healthy subjects and 16 pa- tients of non-malignant hepatic diseases (e.g. cirrho- sis, viral hepatitis and amoebic liver abscess) served
as controls. Positive LAI test was obtained in all the six cases
of HCC (hepatocellular carcinoma) using HCC anti- gen. There was no false positive among both the
control groups whereas 2/21 cases of secondary car-
cinoma of the liver gave false positive tests with HCC
antigen. Using sec. adenocarcinoma liver antigen, 19/21
cases of sec. carcinoma of the liver gave positive tests. There were two false positives among non- malignant liver disease controls and 1 (out of 8) in
HCC. Thus, in the present study LAI test was found to
be helpful in diagnosis of hepatic neoplasia.
Sonographic evolution of hepatocellular carcinoma in its early stage
J.C. SHEU, D.S. CHEN, J.L. SUNG, C.N. CHUANG, P.M. YANG and
J .T. LIN Dept Intern Med, Natl Taiwan Univ Coll
Med, Taipei, Taiwan R. O. C.
To study the sonographic evolution of hepato- cellular carcinoma (HCC) in its early stage, 26 HCCs smaller than 5 cm in 24 patients, were ob-
served regularly by real-time ultrasound for a period of 90 to 691 days. In the beginning, 21 tumors were hypoechoic, 2 isoechoic, and 3 diffusely hyper- echoic. On follow-up, 2 of the 21 initially hypo- echoic HCCs remained in the same echodensity, 12 increased in internal echoes but were still hypo- echoic; 1 became isoechoic, 4 changed to hyper- echoic pattern; and the remaining 2 shifted from hypo- to iso- and then to hyperechoic pattern. The 2 initially isoechoic HCCs also gained echogenecity
and became hyperechoic. By contrast, the 3 initially hyperechoic HCCs kept on the same echofeatures. Those "acquired" hyperechoic HCCs were inhomo- geneous in echodensity and larger in size whereas the
3 origionally hyperechoic HCCs were homogeneous
and smaller. It is concluded that most small HCCs evolve progressively from hypoechoic to iso- then to
inhomogeneously hyperechoic pattern as they grow; a few HCCs get their diffusely high echogenecity
early since their beginning and remain in the same feature thereafter.
Prognostic histologic features of resected hepatocellular
carcinoma in Taiwan
H.C. HSU, J.C. SHEU, Y.H. LIN, D.S. CHEN, C.S. LEE, R.P. BEASLEY and
L.Y. HWANG Dept Pathol, Intern Med, and Surg,
Natl Taiwan Univ, and Univ of Washington Med Res Unit,
Taipei, Taiwan R. O. C.
This study analyzed the morphologic features and
their prognostic significance in 83 surgically resected hepatocellular carcinoma (HCC) which had been
followed up from 10 months up to 4 years, or until recurrence occurred: 44 were of <5 cm in diameter
and 39 were larger. Although small HCC had a higher incidence of cirrhosis (72.7%) than large HCC (43.6%), both had high prevalences of tumor capsule (86.4% and 84.6%, respectively), and HBsAg positivity (93.2% and 87.2%, respectively). However, small HCC had a higher HBsAg positivity in the tumor (40.9%) than large HCC (10.3%), P<0.003. In small HCC, the capsule was more fre- quent in liver with cirrhosis (31/32) than without (7/12), P<0.001. This comparative study demon- strated that the utmost important histologic para- meter influencing the tumor recurrence was the liver invasion for both small (P<(0.001) and large HCC (P<0.05). For small HCC, the extracapsular inva- sion also posed a worse prognosis than without,
P<0.05. The better prognosis of small than large HCC was attributed to the lower incidences of liver invasion (P<0.001), portal vein invasion (P<0.01),
298 Proceedings of26th Annual Meeting Vol. 20, No. 3
and satellite nodule (P<0.01). The tumor recur-
rence did not correlate with the tumor grading,
presence of clear cells, or liver cell dysplasia. These
findings indicate tha t the prognosis of HCC may be
predetermined by the HCC itself.
Metastatic malignancy of liver
Pranesh NIGAM, K.K. K A P O O R and
A.K. G U P T A
Dept Med, BRD Med Coll, Gorakhpur-273013, India
Thir ty cases (25 males, 5 females, mean age=62.5
+ 5.6 yrs) of metas ta t ic mal ignancy of liver were
studied for the clinical profile. Majority of them
(66.6%) presented with non-specific symptoms of
weakness, weight loss, fever, sweating and loss of ap-
petite. Pain over r ight hypochondr ium was sharp
and in te rmi t ten t in 16,6% of cases. Tende r hepato-
negaly with mul t ip le ha rd nodules were observed in
53 .3% of cases. Jaundice was deep in 13.3% and
mild in 6 .6% of cases. Friction rub over liver area
was audible in 10% and splenomegaly in 50% of
cases. Right supra-clavicular lymph glands were en-
larged in 6 .6%. Oedema over leg was seen in 33 .3%
of cases. Blood stained pleural effusion and ascites
was seen in 6.6 % and 13.3 % of cases respectively.
Hyperb i l i rub inaemia was present in 23 .3% of
cases. Serum alk. phosphatase, lactic dehydrogenase
and t ransaminases levels were raised in all of them.
Ratio of lactic dehydrogenase in ascitic fluis and
serum was more t han 3 in 13.3% of cases. Trea t -
ment of these cases remained highly unsatisfactory
with survival of 3-6 months from the diagnosis
established.